Filter
372
Text search:
antibodies
Featured
Recommendations
40
New Publications
81
Language
Document type
No document type
172
Guidelines
71
Studies & Reports
55
Fact sheets
26
Manuals
22
Training Material
10
Strategic & Response Plan
8
Brochures
2
Situation Updates
2
Videos
2
App
1
Resource Platforms
1
Countries / Regions
Global
24
India
23
Nigeria
12
South Africa
7
Sierra Leone
6
Tanzania
6
Brazil
6
Syria
5
Kenya
5
Liberia
4
Congo, Democratic Republic of
4
Uganda
4
Philippines
4
Western and Central Europe
4
Venezuela
4
Russia
4
Ethiopia
3
Nepal
3
Germany
3
Rwanda
3
Namibia
3
Latin America and the Carribbean
3
Africa
3
Cameroon
2
Pakistan
2
South Sudan
2
Afghanistan
2
Malawi
2
Ukraine
2
Lesotho
2
Myanmar / Burma
2
Guinea
1
Saudi Arabia
1
Zimbabwe
1
Haiti
1
Zambia
1
Turkey
1
Papua New Guinea
1
North Macedonia
1
Ecuador
1
Yemen
1
Middle East and North Africa
1
South–East Asia Region
1
Eastern Europe
1
Southern Africa
1
Tajikistan
1
Uzbekistan
1
Kazakhstan
1
Georgia
1
Vietnam
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
103
Clinical Guidelines
65
Pharmacy & Technologies
20
Women & Child Health
18
Public Health
14
Key Resources
9
Capacity Building
6
Toolboxes
COVID-19
66
NTDs
45
HIV
41
TB
16
Rapid Response
14
Zika
10
Refugee
9
Ebola & Marburg
8
Mental Health
8
NCDs
7
Polio
6
Caregiver
6
Pharmacy
5
AMR
4
Planetary Health
4
Malaria
4
Natural Hazards
3
Cholera
2
2.0 Rapid Response
2
Conflict
1
Specific Hazards
1
September 2021
10 May 2021
This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020.
This update is focused on what is currently understood about SARS-CoV-2 immunity from natural infection. More information about considera
...
The Lancet Volume 5, Issue 10100972October 2024 Chagas Disease Serie 3
Interim Guidance
Отчет оценочной
миссии
Январь 2014 г
Natural immunity against COVID-19
Scientific report 10 May 2021
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th
...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani
...
PLoS Negl Trop Dis 18(7): e0012282.
This review highlights common diagnostic
approaches for detecting schistosomiasis in field and clinical settings, major challenges,
and provides new and novel opportunities and diagnosis pathways that will be critical in sup-
porting elimination of schistosomi
...
A Practical Guide.
The Regional strategy for measles control recommends that a second opportunity for measles immunization be provided to all children irrespective of their vaccination status or history of clinical measles. The preferred method of provision of a second opportunity is through Supplemental Immunization
...
Emergency WASH in Health Facilities in Conflict Affected Locations 756 health workers trained on disease surveillance and outbreak response.
Around 142 health workers trained on integrated health (WASH and Nutrition) response. 405 health facilities are equipped with functional incinerators.
Qual
...
